Shiseido Japan to take over Shiseido Pharmaceutical through company split, effective Jan. 1, 2024; move targets new growth opportunities in 'Clean and Dermatology' and 'Inner Beauty' domains among Japanese consumers

Sample article from our Beauty & Personal Care

May 22, 2023 (press release) –

It is hereby notified that wholly owned subsidiaries of Shiseido Company, Limited (the “Company”) Shiseido Japan Company, Limited and Shiseido Pharmaceutical Company, Limited have each made institutional decisions that they would let Shiseido Japan, which controls the domestic marketing and sales operations of its brands as the regional headquarters of The Shiseido Group in Japan, take over Shiseido Pharmaceutical’s business through a company split (absorption-type split). This will come into effect on January 1, 2024.

1.Purpose of this absorption-type split

The Shiseido Group has established its medium-term management strategy of “SHIFT 2025 and Beyond” and, under a new management structure, will shift itself from “Defense” to “Offense” and enhance further growth to “Be a Global Winner with Our Heritage.” Then, as a Personal Skin Beauty & Wellness Company in 2030, it will continue to aspire to realize a sustainable world where everyone can enjoy a lifetime of happiness through the power of beauty.
Under these circumstances, the Company has targeted the “Clean & Dermatology*” and “Inner Beauty” domains, which continue to grow, as new growth opportunities to capture the changes among Japanese consumers, and will create new demand and deliver value by strengthening initiatives in these domains. Thus the business of Shiseido Pharmaceutical, which has brands in these domains, will be transferred to Shiseido Japan, which operates cosmetics and health care businesses in Japan, in the form of an absorption-type split.

*A market area that combines clean cosmetics which do not contain ingredients that are considered to be likely to stimulate the skin, and dermatological cosmetics that are based on dermatological science.

2.About Shiseido Pharmaceutical Company, Limited

(1) Address:7-5-5 Ginza, Chuo-ku, Tokyo
(2) Representative:Kazuhiro Ota, Representative Director, President
(3) Business description:Sales of pharmaceuticals, cosmetics, etc.
(4) Date of establishment:August 1, 1987

*The content of the release is correct as of the time of release, but please note that it may in some cases differ from the latest information.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Jason Irving
Jason Irving
- SVP Enterprise Solutions -

We offer built-to-order beauty & personal care coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.